29 related articles for article (PubMed ID: 15220700)
1. Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts.
de Waal R; Rabie H; Technau KG; Eley B; Sipambo N; Cotton M; Boulle A; Wood R; Tanser F; Fatti G; Egger M; Davies MA;
Antivir Ther; 2023 Feb; 28(2):13596535231168480. PubMed ID: 37038365
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa?
Lee GQ; McCluskey S; Boum Y; Hunt PW; Martin JN; Bangsberg DR; Gao X; Harrigan PR; Haberer JE; Siedner MJ
J Acquir Immune Defic Syndr; 2017 Oct; 76(2):188-192. PubMed ID: 28639996
[TBL] [Abstract][Full Text] [Related]
3. A Case of Transient Hyperlactatemia Induced by Intravenous Glycerol Administration in a Patient With Brain Trauma.
Fujise T; Nihei SI; Yamashita M; Takahashi Y; Uchida T; Otsuji K; Aibara K; Kamochi M
J UOEH; 2024; 46(1):17-21. PubMed ID: 38479870
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
[TBL] [Abstract][Full Text] [Related]
5. Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.
Crain MJ; Chernoff MC; Oleske JM; Brogly SB; Malee KM; Borum PR; Meyer WA; Mitchell WG; Moye JH; Ford-Chatterton HM; Van Dyke RB; Seage Iii GR
J Infect Dis; 2010 Jul; 202(2):291-301. PubMed ID: 20533872
[TBL] [Abstract][Full Text] [Related]
6. Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?
Castelnuovo B; Nanyonjo A; Kamya M; Ocama P
Afr Health Sci; 2008 Jun; 8(2):133-4. PubMed ID: 19357764
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy.
Funk MJ; Belinson SE; Pimenta JM; Morsheimer M; Gibbons DC
Drug Saf; 2007; 30(10):845-59. PubMed ID: 17867723
[TBL] [Abstract][Full Text] [Related]
8. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
9. From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.
Curran A; Ribera E
Expert Opin Drug Saf; 2011 May; 10(3):389-406. PubMed ID: 21235431
[TBL] [Abstract][Full Text] [Related]
10. Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine.
Lonergan JT; McComsey GA; Fisher RL; Shalit P; File TM; Ward DJ; Williams VC; Hessenthaler SM; Lindsey L; Hernandez JE;
J Acquir Immune Defic Syndr; 2004 Aug; 36(4):935-42. PubMed ID: 15220700
[TBL] [Abstract][Full Text] [Related]
11. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
Carr A; Workman C; Smith DE; Hoy J; Hudson J; Doong N; Martin A; Amin J; Freund J; Law M; Cooper DA;
JAMA; 2002 Jul; 288(2):207-15. PubMed ID: 12095385
[TBL] [Abstract][Full Text] [Related]
12. Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.
Shulman NS; Hughes MD; Winters MA; Shafer RW; Zolopa AR; Hellmann NS; Bates M; Whitcomb JM; Katzenstein DA
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):121-7. PubMed ID: 12394789
[TBL] [Abstract][Full Text] [Related]
13. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
Eron JJ; Murphy RL; Peterson D; Pottage J; Parenti DM; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum BC; Esinhart J; Schoellkopf N; Grosso R; Stevens M
AIDS; 2000 Jul; 14(11):1601-10. PubMed ID: 10983647
[TBL] [Abstract][Full Text] [Related]
14. A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression.
Saez-Llorens X; Castaño E; Rathore M; Church J; Deville J; Gaur A; Estripeaut D; White K; Arterburn S; Enejosa JV; Cheng AK; Chuck SL; Rhee MS
Pediatr Infect Dis J; 2015 Apr; 34(4):376-82. PubMed ID: 25760565
[TBL] [Abstract][Full Text] [Related]
15. Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only?
Stephan C; Dauer B; Khaykin P; Stuermer M; Gute P; Klauke S; Staszewski S
Curr HIV Res; 2009 May; 7(3):320-6. PubMed ID: 19442129
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
